Evidence map›Paper›PMID 41008918›Full record

ArticleCancers2025

Tingyong Cao, Yurong Zhang, Huan Liu, Hongbin Zhang, Liangliang Li, Xiaoli Li, Li Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tingyong CaoThe First Clinical Medical College, Lanzhou University, Lanzhou 730000, China.
Yurong ZhangDepartment of Hematology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China.
Huan LiuDepartment of Hematology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China.
Hongbin ZhangDepartment of Hematology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China.
Liangliang LiDepartment of Hematology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China.
Xiaoli LiDepartment of Nephrology, Gansu Provincial Hospital, Lanzhou 730000, China.
Li ZhaoGansu Provincial Clinical Medical Research Center for Molecular Diagnosis and Treatment of Hematological Diseases, The First Hospital, Lanzhou University, Lanzhou 730000, China.

Funding

Gansu Province Youth Science and Technology Fund program No.25JRRA1029
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMLapoptosiscell cyclemigrationPARP3PI3K/AKT/mTOR signaling

Identifiers

PMID41008918
PMCPMC12468979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.